Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 23801608)

1.

Occupational exposure to hepatitis C virus: early T-cell responses in the absence of seroconversion in a longitudinal cohort study.

Heller T, Werner JM, Rahman F, Mizukoshi E, Sobao Y, Gordon AM, Sheets A, Sherker AH, Kessler E, Bean KS, Herrine SK, Stevens M, Schmitt J, Rehermann B.

J Infect Dis. 2013 Sep;208(6):1020-5. doi: 10.1093/infdis/jit270. Epub 2013 Jun 24.

2.

Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection.

Abdelwahab SF, Zakaria Z, Sobhy M, Rewisha E, Mahmoud MA, Amer MA, Del Sorbo M, Capone S, Nicosia A, Folgori A, Hashem M, El-Kamary SS.

Clin Vaccine Immunol. 2012 May;19(5):780-6. doi: 10.1128/CVI.00050-12. Epub 2012 Mar 21.

3.

Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort.

Post JJ, Pan Y, Freeman AJ, Harvey CE, White PA, Palladinetti P, Haber PS, Marinos G, Levy MH, Kaldor JM, Dolan KA, Ffrench RA, Lloyd AR, Rawlinson WD; Hepatitis C Incidence and Transmission in Prisons Study (HITS) Group.

J Infect Dis. 2004 May 15;189(10):1846-55. Epub 2004 Apr 26.

4.

Innate immune responses in hepatitis C virus-exposed healthcare workers who do not develop acute infection.

Werner JM, Heller T, Gordon AM, Sheets A, Sherker AH, Kessler E, Bean KS, Stevens M, Schmitt J, Rehermann B.

Hepatology. 2013 Nov;58(5):1621-31. doi: 10.1002/hep.26353. Epub 2013 Sep 30.

6.

Strong hepatitis C virus (HCV)-specific cell-mediated immune responses in the absence of viremia or antibodies among uninfected siblings of HCV chronically infected children.

Hashem M, El-Karaksy H, Shata MT, Sobhy M, Helmy H, El-Naghi S, Galal G, Ali ZZ, Esmat G, Abdelwahab SF, Strickland GT, El-Kamary SS.

J Infect Dis. 2011 Mar 15;203(6):854-61. doi: 10.1093/infdis/jiq123. Epub 2011 Jan 21.

7.

Prolonged hepatitis C virus seroconversion in a blood donor, detected by HCV antigen test in parallel with HCV RNA.

Alvarez M, Planelles D, Vila E, Montoro J, Franco E.

Vox Sang. 2004 May;86(4):266-7. No abstract available.

PMID:
15144533
8.

Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response.

Meyer MF, Lehmann M, Cornberg M, Wiegand J, Manns MP, Klade C, Wedemeyer H.

Virol J. 2007 Jun 11;4:58.

9.

Loss of virus-specific T-cell responses in HCV exposed uninfected injection drug users with drug rehabilitation.

Thurairajah PH, Hegazy D, Demaine A, Kaminski ER, Cramp ME.

J Infect Dis. 2011 Mar 15;203(6):847-53. doi: 10.1093/infdis/jiq121.

10.

Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection.

Park SH, Veerapu NS, Shin EC, Biancotto A, McCoy JP, Capone S, Folgori A, Rehermann B.

Nat Med. 2013 Dec;19(12):1638-42. doi: 10.1038/nm.3408. Epub 2013 Nov 24.

11.

[Risk factors for hepatitis C virus transmission to Health Care Workers after occupational exposure: a European case-control study].

Yazdanpanah Y, De Carli G, Migueres B, Lot F, Campins M, Colombo C, Thomas T, Deuffic-Burban S, Prevot MH, Domart M, Tarantola A, Abiteboul D, Deny P, Pol S, Desenclos JC, Puro V, Bouvet E.

Rev Epidemiol Sante Publique. 2006 Jul;54 Spec No 1:1S23-1S31. French.

PMID:
17073127
12.

Humoral immune response in acute hepatitis C virus infection.

Netski DM, Mosbruger T, Depla E, Maertens G, Ray SC, Hamilton RG, Roundtree S, Thomas DL, McKeating J, Cox A.

Clin Infect Dis. 2005 Sep 1;41(5):667-75. Epub 2005 Jul 22.

13.

The cellular immune responses induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcome.

Löhr HF, Gerken G, Roth M, Weyer S, Schlaak JF, Meyer zum Büschenfelde KH.

J Hepatol. 1998 Oct;29(4):524-32.

PMID:
9824260
14.

Viral clearance or persistence after acute hepatitis C infection: interim results from a prospective study.

Guobuzaite A, Chokshi S, Balciūniene L, Voinic A, Stikleryte A, Zagminas K, Ambrozaitis A, Naoumov N.

Medicina (Kaunas). 2008;44(7):510-20.

15.

Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV.

Mizukoshi E, Eisenbach C, Edlin BR, Newton KP, Raghuraman S, Weiler-Normann C, Tobler LH, Busch MP, Carrington M, McKeating JA, O'Brien TR, Rehermann B.

J Infect Dis. 2008 Jul 15;198(2):203-12. doi: 10.1086/589510.

16.

Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection.

Kim AY, Schulze zur Wiesch J, Kuntzen T, Timm J, Kaufmann DE, Duncan JE, Jones AM, Wurcel AG, Davis BT, Gandhi RT, Robbins GK, Allen TM, Chung RT, Lauer GM, Walker BD.

PLoS Med. 2006 Dec;3(12):e492.

17.

Hepatitis C virus (HCV)--specific T cell responses in injection drug users with apparent resistance to HCV infection.

Thurairajah PH, Hegazy D, Chokshi S, Shaw S, Demaine A, Kaminski ER, Naoumov NV, Cramp ME.

J Infect Dis. 2008 Dec 15;198(12):1749-55. doi: 10.1086/593337.

18.
19.

Exposure to hepatitis C virus induces cellular immune responses without detectable viremia or seroconversion.

Al-Sherbiny M, Osman A, Mohamed N, Shata MT, Abdel-Aziz F, Abdel-Hamid M, Abdelwahab SF, Mikhail N, Stoszek S, Ruggeri L, Folgori A, Nicosia A, Prince AM, Strickland GT.

Am J Trop Med Hyg. 2005 Jul;73(1):44-9.

20.

Transient loss of T-cell reactivity in a patient with hepatitis C virus reinfection.

Düesberg U, Geulen O, Schneiders AM, Kaiser R, Brackmann HH, Matz B, Sauerbruch T, Spengler U.

Digestion. 2001;64(1):66-70.

PMID:
11549839
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk